BeOne Medicines Ltd.

ONC · Nasdaq · SIC 2834: Pharmaceutical Preparations
302
SEC Filings

Business Summary

BeOne Medicines Ltd. (formerly BeiGene) is a global oncology company focused on developing and commercializing innovative medicines for cancer patients. The company develops both small molecule and large molecule biologic therapies, operates its own manufacturing facilities, and markets approved medicines across the U.S., China, EU, UK, Switzerland, and other international markets. It also engages in strategic collaborations and licensing arrangements to expand its pipeline.

Next Earnings

Q2 FY2026 — expected 2026-08-19

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionONCdiscussed_in_filing Cybersecurity
topic_mentionONCdiscussed_in_filing Trusted Computing
topic_mentionONCdiscussed_in_filing Blockchain & Crypto
topic_mentionONCdiscussed_in_filing Regulation
topic_mentionONCdiscussed_in_filing Healthcare & Bio
topic_mentionONCdiscussed_in_filing Sovereign & Government
topic_mentionONCdiscussed_in_filing Cybersecurity
topic_mentionONCdiscussed_in_filing Trusted Computing
topic_mentionONCdiscussed_in_filing Blockchain & Crypto
topic_mentionONCdiscussed_in_filing Regulation
topic_mentionONCdiscussed_in_filing Healthcare & Bio
topic_mentionONCdiscussed_in_filing Sovereign & Government
topic_mentionONCdiscussed_in_filing Cybersecurity
topic_mentionONCdiscussed_in_filing Trusted Computing
topic_mentionONCdiscussed_in_filing Blockchain & Crypto
topic_mentionONCdiscussed_in_filing Regulation
topic_mentionONCdiscussed_in_filing Healthcare & Bio
topic_mentionONCdiscussed_in_filing Sovereign & Government
topic_mentionONCdiscussed_in_filing Cybersecurity
topic_mentionONCdiscussed_in_filing Trusted Computing

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001628280-26-011946EDGAR136K words
2025-02-272024-12-310001651308-25-000031EDGAR
2024-02-262023-12-310001651308-24-000014EDGAR
2023-02-272022-12-310001651308-23-000036EDGAR
2022-02-282021-12-310001651308-22-000032EDGAR
2021-02-252020-12-310001651308-21-000039EDGAR
2020-03-022019-12-310001651308-20-000020EDGAR
2019-02-282018-12-310001651308-19-000018EDGAR
2018-02-282017-12-310001558370-18-001303EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001628280-25-049824EDGAR71K words
2025-08-062025-06-300001651308-25-000133EDGAR
2025-05-072025-03-310001651308-25-000075EDGAR
2024-11-122024-09-300001651308-24-000152EDGAR
2024-08-072024-06-300001651308-24-000098EDGAR
2024-05-082024-03-310001651308-24-000051EDGAR
2023-11-092023-09-300001651308-23-000165EDGAR
2023-08-022023-06-300001651308-23-000127EDGAR
2023-05-042023-03-310001651308-23-000068EDGAR
2022-11-092022-09-300001651308-22-000209EDGAR
2022-08-082022-06-300001651308-22-000139EDGAR
2022-05-092022-03-310001651308-22-000071EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-260001628280-26-011941EDGAR8K words
2025-12-190001651308-25-000153EDGAR
2025-12-180001651308-25-000151EDGAR
2025-11-190001651308-25-000148EDGAR
2025-11-060001628280-25-049821EDGAR
2025-08-290001651308-25-000136EDGAR
2025-08-250001628280-25-041082EDGAR
2025-08-060001651308-25-000131EDGAR
2025-05-210001651308-25-000084EDGAR
2025-05-130001651308-25-000078EDGAR

302 total filings indexed. 271 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Tags

oncology united-states china european-union united-kingdom switzerland international-markets

Company Identity

CIK0001651308
TickerONC
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 4f1ac2daf271a8af14e8bb5ab58bfc924478096648e0987c04fce023692b3bf6
parent: 11eb37b71a91b852a97b1564b733e91e7f204ee873619b2b0a5981c4279926de
content hash: 1608651b625e485786cb6464562223733bbd1f5ff517b7f8115d856a1567458d
signed: 2026-04-13T04:46:43.486Z
sources: 21 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf